A new study published in the Journal of Urology Open Plus reported that seven of 28 popular saw palmetto products met the identity and potency standards to effectively relieve urinary tract symptoms associated with an enlarged prostate.
High prices, “unscrupulous suppliers”, and inadequate identification methods have resulted in adulteration rates of saw palmetto extracts reaching 33% in Japan and as high as 75% in other Asian markets, says BGG World.
Valensa’s Supercritical CO2 extract from Saw Palmetto (USPlus) may support prostate health by inhibiting the conversion of testosterone to dihydrotestosterone, according to a new study.
Researchers in Italy suggest that supplementation with French Maritime Pine extract may help manage benign prostatic hypertrophy, also known as enlarged prostate.
UK firm Healthspan has been told to amend marketing materials for herbal-based blends after the Advertising Standards Authority (ASA) found advertorial materials in breach of its fair marketing code for making medicinal and unauthorised claims.
Safety concerns over saw palmetto supplements for prostate health
may be unfounded, according to a new study from the US that
reported no adverse effects.
The withdrawal of supplements containing saw palmetto from the
Danish market is due to a 2002 evaluation that expressed concerns
about the effect the botanical has on hormones,
NutraIngredients.com has learned.
Contrary to earlier reports, saw palmetto, the extract from the
berries of a dwarf palm tree, has no effect on non-cancerous
prostate swellings, claims that have been called "puzzling" by a
leading herbal expert.
A recent study published in the American Journal of Clinical
Nutrition explored the connections between nutrition and the
risk of developing benign prostatic hyperplasia (BPH) in a large
group of male health professionals. Benign...